3 ways generative AI is reshaping the patient experience
Mistrust and bias are key barriers to realizing the potential of AI in healthcare but addressing the accuracy and economy of large language models can help.
Pratap was elected CEO of ZS in July 2021. ZS is a 11,500-strong global healthcare consultancy. Prior to this, he led the firm’s global Pharmaceuticals practice for 9 years and founded and led its Advanced Data Science capability which focuses on AI. He has also served on ZS’s board since 2012, and on the Board of Virtua Health System since 2015. He holds a PhD in AI from UC Berkeley.
Mistrust and bias are key barriers to realizing the potential of AI in healthcare but addressing the accuracy and economy of large language models can help.
A new report from the World Economic Forum makes a strong case for the safe use of AI in healthcare.
AI could revolutionize drug discovery and healthcare, but AI’s impact on global health depends on representative data, trustworthy design and scalability.
Already, AI in healthcare solutions have proven more efficient and have become more effective and the challenge remains in scaling up these technologies.